Alteogen

Beta

KRX Filings & Disclosures 2026

Management Discussion & Analysis

• • Alteogen (알테오젠) FY2025 revenue KRW 215.9B (+109.9% YoY); operating profit KRW 106.9B (+320.8%); net income KRW 145.2B (+139.2%)
• • Growth driven by ALT-B4 license upfront payments from multinational pharma partners (MSD, AstraZeneca, GSK, Daiichi Sankyo, Sandoz)

Risk Factors

• • FX sensitivity: 10% move in USD/EUR rates impacts pre-tax profit by ±KRW 21.5B (current year) vs ±KRW 5.3B (prior year) — 4x increase in FX exposure YoY
• • Foreign currency financial assets KRW 230.9B vs liabilities KRW 16.1B; net long USD/EUR position dominated by USD 104.6M in short-term financial instruments

Business Overview

• • Platform biotech licensing IV-to-SC hyaluronidase tech (Hybrozyme™/ALT-B4) to MSD, AstraZeneca, GSK, Daiichi Sankyo, Sandoz; revenue via upfront, milestones, royalties
• • Total revenue KRW 215.9B in FY2025, up 110% YoY from KRW 102.9B; tech licensing revenue KRW 169.4B (78.5% of total), up ~124% YoY

What are the latest Alteogen DART filings in 2026?

Alteogen (KRX code 196170) has filed an annual report on March 23, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Alteogen file its most recent annual report?

Alteogen filed its most recent annual report on March 23, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Alteogen's KRX stock code?

Alteogen's KRX stock code is 196170. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 196170 to look up all Alteogen disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Alteogen file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Alteogen.

Where can I find Alteogen financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Alteogen annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.